Aspira Women's Health Inc... (AWH)
| Bid | 0.09 |
| Market Cap | 1.64M |
| Revenue (ttm) | 10.28M |
| Net Income (ttm) | -16.97M |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -0.08 |
| Forward PE | -0.82 |
| Analyst | Hold |
| Ask | 0.1 |
| Volume | 1,918,378 |
| Avg. Volume (20D) | 4,195,706 |
| Open | 0.10 |
| Previous Close | 0.10 |
| Day's Range | 0.09 - 0.10 |
| 52-Week Range | 0.09 - 3.75 |
| Beta | 1.57 |
About AWH
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service fo...
Analyst Forecast
According to 2 analyst ratings, the average rating for AWH stock is "Hold." The 12-month stock price forecast is $4.4, which is an increase of 4631.18% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · accessnewswire.com
Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of DirectorsAUSTIN, TX / ACCESS Newswire / February 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyne...